Tech Company Financing Transactions
MonoSol Rx Funding Round
MonoSol Rx, operating out of Warren, secured $20 million in funding from CNF Investments and private investors.
Transaction Overview
Company Name
Announced On
9/30/2008
Transaction Type
Venture Equity
Amount
$20,000,100
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
30 Technology Dr.
Warren, NJ 07059
USA
Warren, NJ 07059
USA
Phone
Website
Email Address
Not Recorded
Overview
MonoSol Rx is a leading drug delivery company specializing in the development and commercialization of thin film pharmaceutical and over-the-counter (OTC) drug products. The Company's thin film formulations offer significant patient benefits, including convenience, taste and potentially greater efficacy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Schobel
Chief Financial Officer
Keith Kendall
VP - Bus. Development
Daniel Barber
VP - Human Resources
Theresa Wood
Browse more venture capital transactions:
Prev: 9/30/2008: TrueDemand Software venture capital transaction
Next: 9/30/2008: Freedom Meditech venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs